johnson  johnson jnj stock rose 09 in premarket trades on tuesday after the drug company’s profit outlook for 2023 topped analyst estimates jj’s fourthquarter profit fell 257 to 352 billion or 133 a share from 474 billion or 177 a share in the yearago period the company’s adjusted net income in the latest quarter totaled 235 a share ahead of the wall street analyst estimate of 223 a share according to factset data the drug company’s revenue fell 44 to 2371 billion slightly short of the wall street revenue target of 23896 billion looking ahead jj said it expects fullyear 2023 earnings of about 1055 a share or a range of 1045 to 1065 a share ahead of the latest analyst estimate of 1033 a share shares of jj are up 04 in the past 12 months as of monday’s close compared to a 21 drop by the dow jones industrial average over the same time period